People with intermediate-risk scores on coronary artery calcium testing who received statins and intensive health coaching ...
Guttman-Yassky received research support, consulting, or lecture fees on atopic dermatitis from Regeneron, Sanofi, Pfizer, ...
After 2 positive trials, low-dose colchicine’ got the FDA nod for CV reduction but then the CLEAR SYNERGY trial found no ...
MedPage Today on MSN12d
Coronary Plaques Reined in With Coronary Calcium Scans in the PictureFor select risk-enhanced individuals at intermediate risk of coronary artery disease (CAD), researchers found a way to ...
Shah and colleagues take advantage of the presence of maternal and somatic ribosomes in zebrafish and confirm their differential expression during development. The authors convincingly show that ...
Dr Bieber has been a speaker and a consultant for AbbVie, Affibody, Almirall, AnaptysBio, Arena, Asana Biosciences, ASLAN pharma, Bayer Health, BioVerSys, Boehringer Ingelheim, Bristol Myers Squibb, ...
DB has received research grants and speakers/consultancy fees from Pfizer, MSD, AbbVie, UCB, Novartis, Janssen, Boehringer Ingelheim; speakers/consultancy ... Ethics approval METC AMC Amsterdam.
Two years after first announcing the partnership, Boehringer Ingelheim and software firm Veeva Systems have launched ...
The One Medicine Platform replaces 20+ legacy platforms—unifying medicinal development processes & data sources into a ...
Salipro Biotech AB, a Swedish biotech company specialising in the stabilisation of challenging drug targets, today announced a research and license agreement with Boehringer Ingelheim to accelerate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback